Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 10061 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Global Olanzapine Markets, 2018-2023 and 2024-2030 - Rise in the Prevalence of Neurological Conditions Spurring Growth

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2024

Global Hearing Aids Market Insights 2024-2029 - Behind-the-Ear (BTE) Hearing Aids Segment is Forecast to Reach $5.86 Billion by 2029, Growing at a CAGR of 3.97%

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2024

Lowell Farms Inc. Appoints Jamie Schniedwind as Chief Financial Officer

Read more ››
By: GlobeNewswire - 15 Feb 2024

United States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Mesoblast Limited

Caliway Received U.S. FDA Fast Track Designation for CBL-514 for the Treatment of Dercum's Disease

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2024
Related companies:  Caliway Biopharmaceuticals Co., Ltd.

Olansky Dermatology & Aesthetics welcomes Dr. Ajdin Kobic to acclaimed roster

Read more ››
By: GlobeNewswire - 14 Feb 2024

Pennant Announces Fourth Quarter and Year-End 2023 Earnings Release and Call

Read more ››
By: GlobeNewswire - 14 Feb 2024

WW International, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  WW International, Inc.

Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Celularity Inc.

Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Sight Sciences, Inc.

Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Inari Medical, Inc.

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  RxSight Inc.

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Crinetics Pharmaceuticals, Inc.

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Codexis, Inc.

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Adaptive Biotechnologies Corporation

Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Cronos Group Inc.

Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Dyne Therapeutics, Inc.

NurExone Launches Licensing Efforts for ExoTherapy Platform

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  NurExone Biologic Ltd.

ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit

Read more ››
By: GlobeNewswire - 14 Feb 2024
Related companies:  Oric Pharmaceuticals Inc.

Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%

Read more ››
By: GlobeNewswire - 14 Feb 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑